Search for Clinical Trial Results

Monkeypox - 8 Studies Found
Status | Study |
Recruiting |
Study Name: IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo Condition: Monkeypox Virus Infection Date: 2016-09-07 Interventions: Biological: IMVAMUNE® Two doses of attenuated live virus smallpox vaccine (IMVAMUNE®) administ |
Available |
Study Name: Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure Condition:
Date: 2014-03-04 Interventions: Drug: Tecovirimat Oral tablet 600mg daily dose(three capsules, 200 mg/capsule) |
Completed |
Study Name: Phase I Trial of an Investigational Small Pox Medication Condition:
|
Completed |
Study Name: A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses Condition:
|
Withdrawn |
Study Name: SIGA-246 to Treat Smallpox Condition: Vaccinia Date: 2006-03-14 Interventions: Drug: Vaccine: SIGA-246 |
RECRUITING |
Study Name: A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines Condition: Monkeypox Date: 2025-02-17 Interventions: Multivalent ribonucleic acid (RNA)-based vaccine for active immunization against monkeypox administered as intramuscular injection |
ACTIVE_NOT_RECRUITING |
Study Name: A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox Condition: Monkeypox Date: 2025-02-17 Interventions: JYNNEOS is FDA-approved and licensed as a smallpox and monkeypox vaccine in the United States.JYNNEOS is a live vaccine produced from the strain |
RECRUITING |
Study Name: Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV Condition: Monkeypox Date: 2025-02-17 |